Quantum Genomics Société Anonyme reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was EUR 3.02 million compared to EUR 3.16 million a year ago. Net loss was EUR 24.94 million compared to EUR 16.56 million a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.1292 EUR | +1.89% | +9.86% | +21.89% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+21.89% | 4.81M | |
+1.51% | 42.75B | |
+8.57% | 41.34B | |
+49.22% | 41.61B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- ALQGC Stock
- News Quantum Genomics
- Quantum Genomics Société Anonyme Reports Earnings Results for the Full Year Ended December 31, 2022